Latest news with #DislogGroup
Morocco World
09-05-2025
- Business
- Morocco World
EBRD Invests $25 Million in Dislog Group's Expansion in Morocco
Doha – The European Bank for Reconstruction and Development (EBRD) has provided a $25 million equity investment to support Dislog Group in Morocco. According to a statement from the institution, the financing aims to strengthen the company's capital structure and advance its mergers and acquisitions strategy. Founded in 2005, Dislog has established itself as a diversified and integrated Moroccan industrial group. The company is positioned at the heart of what EBRD describes as the 'life economy' with a presence in the hygiene, food, and healthcare sectors. The investment is part of a larger capital increase alongside several co-investors. These include SPE Capital, the International Finance Corporation, Sanam Holding, Sanlam, and H&S Invest Holding. The funds will refinance Dislog Group's recent acquisitions. They will also support the company's deleveraging efforts ahead of its upcoming IPO and contribute to strengthening its financial structure. According to the announcement, Dislog's recent acquisitions are expected to deliver operational synergies. These moves will expand its national footprint and reinforce its position across consumer and healthcare value chains. The transaction has received approval from all relevant authorities. This includes Morocco's Competition Council. DLA Piper and Roland Berger served as legal advisers for the transaction. Read also: EBRD Invests €38 Million in ONCF's Green Bond to Support Morocco's Railway Transition Dislog Group currently manages a portfolio of over 200 brands. These are either owned directly or operated through partnerships. The institution states that the Group contributes to improving consumers' daily lives in Morocco and Europe. The company employs more than 3,400 people. According to EBRD, these employees are committed to promoting innovative and accessible brands that support households. In recent years, Dislog has expanded into the pharmaceutical industry through 'CMB Plastique.' The company now operates across three sectors: hygiene, food, and healthcare. This investment continues EBRD's involvement in Morocco's economy. In a separate recent initiative, EBRD partnered with the European Union and other institutions to provide a €65 million green financing package to Banque marocaine pour le commerce et l'industrie (BMCI). Morocco became a recipient of EBRD resources in 2012 as a founding member of the bank. To date, the EBRD has invested €5.4 billion in the country through 113 projects.
Ya Biladi
09-05-2025
- Business
- Ya Biladi
EBRD backs Morocco's Dislog Group with $25m investment
The European Bank for Reconstruction and Development (EBRD) is investing $25 million in Morocco's Dislog Group to bolster its capital structure and support its mergers and acquisitions strategy. The equity injection is part of a broader capital increase involving SPE Capital, IFC, Sanam Holding, Sanlam, and H&S Invest Holding, aimed at refinancing recent acquisitions and reducing the group's debt ahead of its planned Initial Public Offering (IPO), says a Friday press release by EBRD. Founded in 2005, Dislog is active in the hygiene, food, and healthcare sectors. It operates over 200 brands, employs 3,400 people, and recently expanded into pharma and bottle-molding with CMB Plastique.
Ya Biladi
03-04-2025
- Business
- Ya Biladi
Morocco : Dislog Group acquires majority stake in cardiology specialist Afrobiomedic
Dislog Group continues its expansion in the medical sector by signing a memorandum of understanding to acquire 70% of the shares in Afrobiomedic, a key player in the field of implantable cardiology devices in Morocco. This move is part of the group's external growth strategy (M&A) and aims to strengthen its healthcare division. Founded in 2009, Afrobiomedic specializes in the import and distribution of medical devices for interventional cardiology, structural cardiology, and electrophysiology, with a presence also in vascular interventional neuroradiology. The company benefits from exclusive partnerships with international brands and offers cutting-edge equipment certified to ISO 13485 standards, thereby ensuring high quality for Moroccan healthcare professionals. Driss Nasr, founder and sole shareholder of Afrobiomedic, will retain 30% of the capital and will continue to lead the company to drive its development in Morocco and Africa. This partnership with Dislog Group will accelerate Afrobiomedic's growth by leveraging the synergies and industrial capabilities of the group. Dislog Group, already well-established in the pharmaceutical industry and medical devices, thus strengthens its healthcare division, which includes several specialized entities such as Megaflex, Kosmopharm, Steripharma, Somapharma, Africare, and Dislog Santé. This division is structured around three business units covering the pharmaceutical industry, medical devices, and dermo-cosmetics, creating a complete value chain from drug manufacturing to the distribution of specialized equipment.
Ya Biladi
02-04-2025
- Business
- Ya Biladi
Morocco : Dislog Group acquires majority stake in cardiology specialist Afrobiomedic
Dislog Group continues its expansion in the medical sector by signing a memorandum of understanding to acquire 70% of the shares in Afrobiomedic, a key player in the field of implantable cardiology devices in Morocco. This move is part of the group's external growth strategy (M&A) and aims to strengthen its healthcare division. Founded in 2009, Afrobiomedic specializes in the import and distribution of medical devices for interventional cardiology, structural cardiology, and electrophysiology, with a presence also in vascular interventional neuroradiology. The company benefits from exclusive partnerships with international brands and offers cutting-edge equipment certified to ISO 13485 standards, thereby ensuring high quality for Moroccan healthcare professionals. Driss Nasr, founder and sole shareholder of Afrobiomedic, will retain 30% of the capital and will continue to lead the company to drive its development in Morocco and Africa. This partnership with Dislog Group will accelerate Afrobiomedic's growth by leveraging the synergies and industrial capabilities of the group. Dislog Group, already well-established in the pharmaceutical industry and medical devices, thus strengthens its healthcare division, which includes several specialized entities such as Megaflex, Kosmopharm, Steripharma, Somapharma, Africare, and Dislog Santé. This division is structured around three business units covering the pharmaceutical industry, medical devices, and dermo-cosmetics, creating a complete value chain from drug manufacturing to the distribution of specialized equipment.
Ya Biladi
25-03-2025
- Business
- Ya Biladi
Dislog Group expands in pharma with Farmalac acquisition
DR Dislog Group has announced a strategic partnership with Farmalac to acquire the entire capital of Farmalac in exchange for a share swap with Dislog Group. This move is part of Dislog's external growth strategy (M&A) and will strengthen its position in the pharmaceutical industry, particularly in the distribution of packaging materials and raw materials. Founded in 1997 by the late Luigi Ghizlanzoni, Farmalac is a leading player in the healthcare sector. Since 2022, it has expanded its business to include the marketing of reagents and consumables for laboratories, further solidifying its role as a key supplier. In 2024, Farmalac achieved a turnover of 251 million dirhams, with the majority coming from the pharmaceutical sector. Farmalac will be integrated into Dislog Group's health division, with Mounir Serifi appointed CEO. No additional governance changes are planned. Moncef Belkhayat, President of Dislog Group, expressed excitement over the acquisition, noting that it strengthens the group's health division and expands its offerings to better meet market demands. Founded in 2005, Dislog Group is a Moroccan industrial group operating in the hygiene, food, and health sectors, with a strong presence in both Morocco and Europe. Dislog Group was advised by Maître Rachid Hilmi, while Farmalac was represented by the law firm DLA Piper.
